Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials (Q5122989): Difference between revisions
From MaRDI portal
Created a new Item |
Normalize DOI. |
||
(4 intermediate revisions by 3 users not shown) | |||
Property / DOI | |||
Property / DOI: 10.1002/bimj.200610358 / rank | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1002/bimj.200610358 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W1996036118 / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q80849539 / rank | |||
Normal rank | |||
Property / DOI | |||
Property / DOI: 10.1002/BIMJ.200610358 / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Latest revision as of 16:01, 30 December 2024
scientific article; zbMATH DE number 7251705
Language | Label | Description | Also known as |
---|---|---|---|
English | Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials |
scientific article; zbMATH DE number 7251705 |
Statements
Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials (English)
0 references
25 September 2020
0 references
constraints
0 references
ethical allocation
0 references
minimization
0 references
truncated normal distribution
0 references
two parameter exponential family
0 references